ImmuneWalk Therapeutics raised $7M in Seed financing to expand operations and R&D efforts.
Amount Raised
$7 Million
Round Type
Seed
New YorkBiotechnologyHealth CareTherapeuticsInvestors
Description
ImmuneWalk Therapeutics, a NYC-based clinical stage company focused on modulating immune and inflammatory disease, raised $7M in Seed funding. Backers included institutional investors and the ImmuneWalk management team. The funds will be used to expand operations and R&D efforts. Their lead candidate, IW-601, is in Phase 1 clinical trial.
Quick answer
ImmuneWalk Therapeutics raised $7 Million in a Seed round, dated May 8, 2025. Investors: ImmuneWalk management team. ImmuneWalk Therapeutics is based in New York, New York, United States.
- How much did ImmuneWalk Therapeutics raise?
- ImmuneWalk Therapeutics raised $7 Million in a Seed round on May 8, 2025.
- Who invested in ImmuneWalk Therapeutics?
- ImmuneWalk management team is named as investors in this round.
- What does ImmuneWalk Therapeutics do?
- ImmuneWalk Therapeutics is a clinical-stage biotechnology company dedicated to developing new therapies for immune-inflammatory diseases.
- Where is ImmuneWalk Therapeutics based and how big is it?
- ImmuneWalk Therapeutics is based in New York, New York, United States. Fundz records about 7 employees.
- Who are the decision-makers at ImmuneWalk Therapeutics?
- Fundz holds 1 contact at ImmuneWalk Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ImmuneWalk Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Actio Biosciences raised $66M (Series B) on June 18, 2025.
- Canton Strategic Holdings, Inc. raised $2.5M (Seed) on June 13, 2025.
- Arialys Therapeutics raised $15M on June 13, 2025.
- ADC Therapeutics raised $100M (Private Equity) on June 12, 2025.
- Ensho Therapeutics raised $23M on June 12, 2025.
- Elkedonia raised $13M (Seed) on June 11, 2025.
Who to call at ImmuneWalk Therapeutics, and when
A new round usually means ImmuneWalk Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImmuneWalk Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImmuneWalk Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImmuneWalk Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImmuneWalk Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ImmuneWalk Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.